Shire Inks $2.4B Sale Of Cancer Biz As Takeda Eyes Takeover
Rare disease-focused Shire, led by Davis Polk, unveiled plans Monday to sell its oncology business to Servier SAS for $2.4 billion in cash, as Japan's Takeda considers whether to make a...To view the full article, register now.
Already a subscriber? Click here to view full article